CKD frequently leads to chronic cardiac dysfunction. This complex relationship has been
termed as cardiorenal syndrome type 4 or cardio-renal link. Despite numerous studies and …

Post‐transplant diabetes mellitus (PTDM) shows a relationship with risk factors including
obesity and tacrolimus‐based immunosuppression, which decreases pancreatic insulin …

Background In previous analyses of BENEFIT, a phase 3 study, belatacept-based
immunosuppression, as compared with cyclosporine-based immunosuppression, was …

These guidelines cover the care of patients from the period following kidney transplantation
until the transplant is no longer working or the patient dies. During the early phase …

Advances in maintenance immunosuppression over the past three decades have improved
solid organ transplantation outcomes dramatically. Uninterrupted access to …

Cutaneous wound healing in the pig is frequently used as a model for human cutaneous
wound healing. In this review, we examine the appropriateness of this model for studying …

Thanks to the development of new, more potent and selective immunosuppressive drugs
together with advances in surgical techniques, organ transplantation has emerged from an …

Successful kidney transplantation offers patients with end-stage renal disease the greatest
likelihood of survival. However, cardiovascular disease poses a major threat to both graft …

In kidney transplant recipients, cancer is one of the leading causes of death with a
functioning graft beyond the first year of kidney transplantation, and malignancies account …

Almost every experimental treatment strategy using non-autologous cell, tissue or organ
transplantation is tested in small and large animal models before clinical translation …